Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. CRBU
6. SKYD
7. BBIO
8. OPCH
9. NEOG
10. HALO

Go back to Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company

Bristol Myers Squibb's Turning Point Offer Fair, Says Stifel

June 3, 2022 12:07 PM EDT

On Friday, it was announced that Bristol-Myers Squibb (NYSE: BMY) will acquire Turning Point Therapeutics (NASDAQ: TPTX) for $4.1 billion or $76 a share, more than double Thursday's closing price of $34.16.

Following the news, Stifel analyst Bradley Canino said the cash offer for... More

Citi Reiterates $90 PT on Bristol-Myers Squibb Co. (BMY), 'We expect some FTC scrutiny...but given the Pfizer/ Arena outcome, we remain hopeful'

June 3, 2022 11:39 AM EDT

Citi analyst Andrew Baum reiterated a Buy rating and $90.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY)/

The analyst comments "PFEs ability to close the Arena deal with little FTC scrutiny, coupled with biotechs de-rating has unsurprisingly re-ignited M&A momentum with... More